Prostate carcinoma
|
0.200 |
AlteredExpression
|
disease |
BEFREE |
High expression of PCAT-1 is observed in different types of cancers, including prostate cancer, colorectal cancer, hepatocellular cancer and gastric cancer.
|
30906215 |
2019 |
Prostate carcinoma
|
0.200 |
GeneticVariation
|
disease |
BEFREE |
Furthermore, 4 genes, MSMB, NCOA4, PCAT1, and PPP1R14A, are associated with PrCa in a trans-ethnic meta-analysis (N = 9117).
|
31308362 |
2019 |
Prostate carcinoma
|
0.200 |
Biomarker
|
disease |
BEFREE |
The lncRNA prostate cancer-associated transcript 1 (PCAT-1) showed potential oncogenic roles in different cancers, however its role in HNSCC is not known.
|
30987615 |
2019 |
Prostate carcinoma
|
0.200 |
GeneticVariation
|
disease |
GWASCAT |
12 new susceptibility loci for prostate cancer identified by genome-wide association study in Japanese population.
|
31562322 |
2019 |
Prostate carcinoma
|
0.200 |
AlteredExpression
|
disease |
BEFREE |
The qRT-PCR assay was used to carry out the expression of prostate cancer-associated ncRNA transcripts 1 (PCAT-1) and miR-149-5p.
|
31646561 |
2019 |
Prostate carcinoma
|
0.200 |
AlteredExpression
|
disease |
BEFREE |
This study will explore the expression and effects of prostate cancer-associated ncRNA transcript 1 (PCAT-1) in MM.
|
31777580 |
2019 |
Prostate carcinoma
|
0.200 |
Biomarker
|
disease |
BEFREE |
<b>This study aimed to investigate the role of prostate cancer associated transcript 1 (PCAT1) underlying the molecular mechanisms of prostate cancer.
|
31090454 |
2019 |
Prostate carcinoma
|
0.200 |
GeneticVariation
|
disease |
GWASCAT |
Association analyses of more than 140,000 men identify 63 new prostate cancer susceptibility loci.
|
29892016 |
2018 |
Prostate carcinoma
|
0.200 |
Biomarker
|
disease |
BEFREE |
The long non-coding RNA (lncRNA) prostate cancer-associated ncRNA transcript 1 (PCAT-1) has been shown to promote prostate cancer cell proliferation through c-Myc and is associated with the poor prognosis of CRC patients.
|
28884413 |
2018 |
Prostate carcinoma
|
0.200 |
GeneticVariation
|
disease |
BEFREE |
Prostate cancer-associated non-coding RNA transcript-1(PCAT-1), which is a newly discovered long non-coding RNA, is up-regulated in various cancers.
|
29378170 |
2018 |
Prostate carcinoma
|
0.200 |
GeneticVariation
|
disease |
BEFREE |
Prostate-cancer-associated ncRNA transcript 1 (PCAT-1), a newly discovered lncRNA, was implicated in the progression of multiple tumors.
|
30508953 |
2018 |
Prostate carcinoma
|
0.200 |
GeneticVariation
|
disease |
GWASCAT |
Genetic risk of prostate cancer in Ugandan men.
|
29356057 |
2018 |
Prostate carcinoma
|
0.200 |
AlteredExpression
|
disease |
BEFREE |
Recently, lncRNA PCAT-1 was found to be up-regulated in prostate cancer and hepatocellular carcinoma, exerting oncogenic effects.
|
29291409 |
2018 |
Prostate carcinoma
|
0.200 |
Biomarker
|
disease |
BEFREE |
In conclusion, these findings suggested that PCAT-1 accelerated PC cell proliferation, migration, invasion and suppressed apoptosis by up-regulating FSCN1 mediated via miR-145-5p, hinting a potential therapeutic strategy for PC patients.
|
28922730 |
2017 |
Prostate carcinoma
|
0.200 |
Biomarker
|
disease |
BEFREE |
Prostate cancer-associated transcript1 (PCAT-1) is a novel lncRNA that involved in cell apoptosis and proliferation of prostate cancer.
|
28571676 |
2017 |
Prostate carcinoma
|
0.200 |
GeneticVariation
|
disease |
GWASCAT |
Genome-wide association of familial prostate cancer cases identifies evidence for a rare segregating haplotype at 8q24.21.
|
27262462 |
2016 |
Prostate carcinoma
|
0.200 |
Biomarker
|
disease |
BEFREE |
PCAT1 promotes prostate cancer cell proliferation and tumor growth in vitro and in vivo.
|
27526323 |
2016 |
Prostate carcinoma
|
0.200 |
Biomarker
|
disease |
BEFREE |
Prostate cancer-associated transcript 1 (PCAT-1) is a novel lncRNA that promotes cell proliferation in prostate cancer, however, the effect of PCAT‑1 in hepatocellular carcinoma (HCC) remains to be elucidated.
|
27035680 |
2016 |
Prostate carcinoma
|
0.200 |
GeneticVariation
|
disease |
GWASCAT |
A large multiethnic genome-wide association study of prostate cancer identifies novel risk variants and substantial ethnic differences.
|
26034056 |
2015 |
Prostate carcinoma
|
0.200 |
Biomarker
|
disease |
BEFREE |
Prostate cancer-associated ncRNA transcript 1 (PCAT-1) is one of the lncRNAs involved in cell apoptosis and proliferation of prostate cancer.
|
25731728 |
2015 |
Prostate carcinoma
|
0.200 |
Biomarker
|
disease |
BEFREE |
Prostate cancer-associated transcript 1 (PCAT-1) is a novel lncRNA that promotes cell proliferation in prostate cancer.
|
25934337 |
2015 |
Prostate carcinoma
|
0.200 |
GeneticVariation
|
disease |
GWASCAT |
Two susceptibility loci identified for prostate cancer aggressiveness.
|
25939597 |
2015 |
Prostate carcinoma
|
0.200 |
GeneticVariation
|
disease |
GWASCAT |
Large-scale association analysis in Asians identifies new susceptibility loci for prostate cancer.
|
26443449 |
2015 |
Prostate carcinoma
|
0.200 |
GeneticVariation
|
disease |
BEFREE |
Several nlincRNAs from a prostate cancer associated chromosomal locus, 8q24, are up-regulated in cancer along with other known prostate cancer associated genes including PCAT-1, PVT1, and PCAT-92.
|
25933431 |
2015 |
Prostate carcinoma
|
0.200 |
Biomarker
|
disease |
BEFREE |
Several lncRNAs, such as prostate cancer antigen 3 (PCA3), prostate cancer gene expression marker 1 (PCGEM1), and prostate cancer associated ncRNA transcript 1 (PCAT1), are highly prostate-specific, posing as attractive biomarkers.
|
24836411 |
2014 |